AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus
AbbVie (NYSE: ABBV) today announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. The state-of-the-art campus will integrate advanced manufacturing and laboratory technologies with artificial intelligence (AI) to support the production of AbbVie’s immunology, neuroscience and oncology medicines. This is AbbVie’s first major investment in North Carolina. The AbbVie…





